Disclaimer:
Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
BioFerr 90
Overview
What is BioFerr 90?
Each green film-coated tablet for oral administration
contains:
What does BioFerr 90 look like?

What are the available doses of BioFerr 90?
Sorry No records found.
What should I talk to my health care provider before I take BioFerr 90?
Sorry No records found
How should I use BioFerr 90?
BioFerr™ 90 is
indicated for the treatment of all anemias that are responsive to
oral iron therapy. These include: hypochromic anemia associated with
pregnancy, chronic and/or acute blood loss, metabolic disease, post-surgical
convalescence, and dietary needs.
One tablet daily or as directed by a physician.Do not chew tablet.
What interacts with BioFerr 90?
Sorry No Records found
What are the warnings of BioFerr 90?
Sorry No Records found
What are the precautions of BioFerr 90?
Sorry No Records found
What are the side effects of BioFerr 90?
Sorry No records found
What should I look out for while using BioFerr 90?
Hypersensitivity to any of the
ingredients. Hemolytic anemia, hemochromatosis, and hemosiderosis
are contraindications to iron therapy.
Folic acid alone is improper therapy in the treatment
of pernicious anemia and other megaloblastic anemia where vitamin
B is deficient.
What might happen if I take too much BioFerr 90?
Symptoms: abdominal pain, metabolic acidosis,
anuria, CNS damage, coma, convulsions, death, dehydration, diffuse
vascular congestion, hepatic cirrhosis, hypotension, hypothermia,
lethargy, nausea, vomiting, diarrhea, tarry stools, melena, hematernesis,
tachycardia, hyperglycemia, drowsiness, pallor, cyanosis, lassitude,
seizures, and shock
How should I store and handle BioFerr 90?
StorageStore Pantoprazole Sodium Delayed-Release Tablets, USP at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) []. StorageStore Pantoprazole Sodium Delayed-Release Tablets, USP at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) []. BioFerr™ 90 ( 44523-732-90) is a green, modified rectangle shaped, film-coated tablet, debossed with “F7” on one side and blank on the other, and packaged in bottles of 90.
Clinical Information
Chemical Structure
No Image foundClinical Pharmacology
Oral iron is absorbed most efficiently
when administered between meals. Iron is critical for normal hemoglobin
synthesis to maintain oxygen transport for energy production and proper
function of cells. Adequate amounts of iron are necessary for effective
erythropolesis. Iron also serves as a cofactor of several essential
enzymes, Including cytochromes, which are involved in electron transport.
Folic acid is required for nucleoprotein synthesis and the maintenance
of normal erytropolesis. Folic acid is the precursor of tetrahydrofolic
acid, which is involved as a cofactor for transformylation reactions
In the biosynthesis of purines and thymidylates of nucleic acids.
Deficiency of folic acid may account for the defective deoxyribonucleic
acid (DNA) synthesis that leads to megaloblast formation and megaloblastic
macrocytic anemias. Vitamin B is essential
to growth, cell reproduction, hematopolesis, nucleic acid, and myelin
synthesis. Deficiency may result in megaloblastic anemia or pernicious
anemia.
Non-Clinical Toxicology
Hypersensitivity to any of the ingredients. Hemolytic anemia, hemochromatosis, and hemosiderosis are contraindications to iron therapy.Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemia where vitamin B is deficient.
Dosing for elderly patients should be administered with caution. Due to the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy, dosing should start at the lower end of the dosing range.
Take 2 hours after meals. Do not exceed recommended dose. Discontinue use if symptoms of intolerance appear. The type of anemia and underlying cause or causes should be determined before starting therapy with BioFerr™ 90 tablets. Ensure Hgb, Hct, and reticulocyte count are determined before starting therapy to determine if it needs to be continued without change or if a dose change is indicated. This product contains FD&C Yellow No. 5 (tartrazine) which may cause allergic-type reactions (including bronchial asthma) in certain susceptible persons. Although the overall incidence of FD&C Yellow No. 5 (tartrazine) sensitivity in the general population is low, it is frequently seen in patients who also have aspirin hypersensitivity.
Adverse reactions with iron therapy may include GI irritation, constipation, diarrhea, nausea, vomiting, and dark stools. Adverse reactions with iron therapy are usually transient. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Reference
This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"
While we update our database periodically, we cannot guarantee it is always updated to the latest version.
Review
Professional
Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72Tips
Tips
Interactions
Interactions
A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).